Cite
HARVARD Citation
El Rashedy, A. et al. (2018). Dual Drug Targeting of Mutant Bcr‐Abl Induces Inactive Conformation: New Strategy for the Treatment of Chronic Myeloid Leukemia and Overcoming Monotherapy Resistance. Chemistry & biodiversity. 15 (3), p. n/a. [Online].